I retired early a few years ago. I was the Credit Manager for a mid-sized publicly traded bank. Despite never working in the industry, I took and passed the CFA Level 1 exam. I traditionally have invested in and written about small and micro cap value stocks. I have found as an investor you can get an edge in researching and talking to management of small and micro cap companies that have little or no analyst coverage. About 20-30% of my portfolio are deep value stocks, and that is historically where I have had the best returns.
Dane Capital Management is a private investment management company, open to institutions and accredited investors, that focuses on value and special situations investments. Twitter: @danecapmgmt For more information see: www.danecap.com
Long Cast Advisers (LCA) is a Brooklyn based RIA that provides concentrated small cap investing to individuals, endowments and family offices. We do this with the most differentiated approach - individual stock selection - that is apart from and indifferent to the markets.
Our goal is to maximize the long term returns on client funds by allocating an agreed upon portion to small cap stocks balanced against cash. Then we seek to buy great companies that are changing and if we are right, we hold them. If we are wrong - and that will inevitably happen - we sell them.
With +12 years institutional research experience and +20 years investing our own funds, we know that we are not smarter than the market. But we are more patient and that allows us to envision opportunities unfolding over time, beyond the immediate present or next quarter.
Because we focus on smaller companies, we consider ourselves part owners of the businesses we invest in. We tend to engage with management at least minimally (and occasionally more), we also engage with customers and competitors, and notably, we won't invest in companies that sell products or services we would be ashamed to discuss: As best we can, we avoid businesses that drop bombs on people’s heads, despoil the environment, profit on suffering or await a bigger fool.
We are not market prognosticators. We view prognostication as Marx viewed religion; it is the opiate of the investment masses. Apart from using a benchmark for comparative purposes, and unless there is a direct corollary to a company or its valuation, we are generally indifferent to the overall market.
LCA is licensed and state registered. We use Interactive Brokers as a platform and third-party custodian for separately managed accounts. We describe our business as "the food truck version of a hedge fund" in that we select stocks and manage the portfolio like a fund, but the costs are lower and the approach is completely transparent. We manage appropriateness by allowing the client to select the target allocation between cash and stocks.
LCA's CIO is Avram ("Avi") Fisher and the firm's investment philosophy is informed by his >10 years experience as a sell-side analyst covering large-cap industrials, business services and E&C's, taking only the best parts - the in-depth research - while avoiding the short-term next-quarter beat-raise insanity. He has additional experience in private equity, as a private investigator and as a former cub reporter and writer. He continues to write, here and on his blog, as a way to organize his thoughts and to share some of his ideas with other like-minded patient, small cap investors.
Disclaimer: All content written on Seeking Alpha by Long Cast Advisers is for informational and educational purposes only and should not be construed as a solicitation or recommendation to buy, sell, or hold any specific security or class of security. LCA's opinions expressed herein address only select certain aspects of the companies mentioned and cannot be a substitute for comprehensive investment analysis. Any analysis presented herein is illustrative in nature, limited in scope, and is for discussion purposes only. The information upon which this material is based was obtained from sources believed to be reliable, but has not been independently verified. Therefore, LCA cannot guarantee its accuracy. Any opinions or estimates constitute the author's best judgment as of the date of publication, and are subject to change without notice. Equity investing is subject to various risks including the total loss of capital.
Laughing Water Capital is a concentrated, long biased investment partnership open to accredited investors. We focus on owning pieces of businesses that are suffering from temporary problems or that are misunderstood by the market due to the vagaries of GAAP accounting or some sort of structural impediment. We consider our portfolio companies to be our partners, and we look for our management teams to have significant equity ownership in our companies. Properly incentivized, we expect our management teams to guide the company past their problems, at which point we will benefit from operational improvement and multiple expansion. Patience is essential.
I am an "extreme value" investor, focusing mostly on micro and nanocap companies selling for a steep discount to price/book, price/sales, price/earnings, EV/EBITDA and other traditional measures of value. (Price-to-book is my favorite, by far.) My emphasis is on low priced stocks (especially under $5), since the marketplace is very inefficient in valuing them, as both institutional investors and brokerages increasingly shun them. I am a dyed-in-the-wool contrarian, and like to invest in the most unloved and out of favor sectors of the market, and numerically screen for the best relative values in those out of favor sectors. A key to my success is to buy companies where the insiders are buying in the open market, to confirm the underlying value proposition. I like to buy stocks trading near a multi-year low, and average down aggressively if the stock moves against me (assuming the circumstances for my purchase haven't changed). I like to look for stocks that are being "dumped" from indices (Russell 2000 or S&P 600 Small Cap, most commonly), or subject to tax-loss selling, creating arbitrary selling pressure in a tight time window. I also like special situations, including selective leveraged turnaround situations, that I can catch at their "inflection" point. I have achieved outsized annualized returns, over the last 27 years, with these strategies. I also take 5%+ positions in companies, and engage in selective shareholder activism, to hold accountable the insular and/or corrupt boards that are sadly all too common, especially in smaller, family-run public companies. I HATE, and decry, index investing, as stocks that are "over-demanded" are going to be over-PRICED, which offsets the miniscule savings of avoiding the "extra cost" of an active manager.
A native of Chicago, I have a B.S. in accounting (1990) from DePaul University, am a former federal financial institution examiner, and am currently an elected City Councilman in my adopted home town of La Porte, Indiana. I love old houses, live in one designed by architect Franklin Burnham (who also designed the Georgia State Capitol), and currently sit on the board of directors of the Parents Television Council, a nationwide non-profit, and the most consequential and compelling charitable organization known to man.
Seeking Alpha's product team is responsible for the development of all of our product-related projects from start to finish. These projects include the Seeking Alpha Portfolio apps on the App Store and Google Play, our Real Time email alert product, and optimization across the Seeking Alpha website.
The purpose of this profile is to allow us to share with our readers all new product developments. Please follow us on Seeking Alpha to receive updates. We look forward to your input and feedback!
SA Product Team
Wall Street Breakfast, Seeking Alpha's flagship daily business news summary, is a one-page summary that gives you a rapid overview of the day's key financial news. It's designed for easy readability on the site or by email (including on mobile devices), and is published before 7:00 AM ET every market day.
Wall Street Breakfast readership of over 900,000 includes many from the investment-banking and fund-management industries.
Sign up here to receive the Wall Street Breakfast in your inbox every business day: http://seekingalpha.com/account/email_preferences
2nd Market Capital Advisory specializes in the analysis and trading of real estate securities. Through a selective process and consideration of market dynamics, we aim to construct portfolios for rising streams of dividend income and capital appreciation.I am an investment adviser representative of 2nd Market Capital Advisory Corporation.
Brad Thomas is a research analyst and he currently writes weekly for Forbes and Seeking Alpha where he maintains research on many publicly-listed REITs. In addition, Thomas is the Editor of the Forbes Real Estate Investor, a monthly subscription-based newsletter.
Thomas has also been featured in Forbes Magazine, Kiplinger’s, US News & World Report, Money, NPR, Institutional Investor, GlobeStreet, CNN, Newsmax, and Fox. He is the #1 contributing analyst on Seeking Alpha in 2014, 2015, 2016, and 2017 (based on page views).
Thomas has co-authored a book, The Intelligent REIT Investor, and is the author of The Trump Factor: Unlocking The Secrets Behind The Trump Empire (available on Amazon).
Thomas received a Bachelor of Science degree in Business/Economics from Presbyterian College and he is married with 5 wonderful kids.
Rakshiet Jain is an astute commercial real estate investor with significant experience in private and public markets across various property types and locations across the U.S. Investment experience includes direct property acquisitions, recapitalizations, distressed debt, CMBS, CRE-CDOs, REIT Debt, Preferred Equity and Common Equity.
I intend to write as and when I get good ideas and topics to cover and have had the time to do good research on the same.
Have made bundles in rust belt. Have made-- and lost-- bundles in high tech.
Former registered rep, business degree, doing vc and private company investments, while looking for stock picks on a regular basis.
Private equity, asset management and equity analyst professional with accomplished academic background. Harvard graduate and fellow, INSEAD and London Business School graduate.
Favorite quote: "It is easier to fool people than to convince them that they have been fooled." Mark Twain
Grumpy Bear is a former research analyst who now invests his own money and provides independent research opinions. Most of the research is focused on short ideas because there are enough sell side analysts and paid promoters hyping stocks on the long side.
Hedge fund manager & Short seller - 10+ years on the buy-side at Multi-Bn Hedge Funds. Now exposing terminal shorts, promotion schemes, and legal frauds.
Tips/ideas on companies misleading investors can be sent to email@example.com. I always welcome collaboration and have respect for your anonymity. There are multiple ways to submit documents anonymously please reach out.
Any proceeds from Seekingalpha.com to Fuzzy Panda will be donated to SIRF Foundation (http://sirf-online.org/donations/) in order to support great investigative reporting.
The rat is the ultimate generalist. It survives many conditions, eats a variety of food, and crawls from the toilet after being flushed.
Investing favors the rat. Don't specialize in one method or asset class. Don't depend on optimal conditions to thrive. There's opportunity in all markets for those who aren't doctrinaire.
Specialists are at a disadvantage. They don't see deals in better places and can't change their investment approach when necessary.
All trades can be assessed through the Kelly Criterion. We take a bet if it has an edge. It doesn't matter if it's a value investment, short sale, or high flying IPO. I prefer to keep my mind open and have more options.
I look for companies with a margin of safety to their value, and I dislike downside risk. I subscribe to the first rule of investing: "Do not lose money."
I believe small and microcap stocks are the best place to look for value in the markets, as most people overlook these companies, making them more likely to be mis-priced. To exploit these opportunities, I have a subscription service with multiple microcap calls every month.
I am a high yield/distressed credit and deep value/reorg equity analyst. I have fundamental research and buy-side direct investing experience of 22 years in four continents, last 13 years of which were in US and 9 years in three emerging nations - India, Australia and Oman. My last job was with Dalton Investments LLC in Los Angeles, where I spent 13 years as Managing Director analyzing special situations, high yield/distressed credits, bank loans and reorg equities. As a generalist, I looked at more than 400 companies and gained knowledge in insolvency proceedings. By participating in creditor committees, I also gained expertise in corporate reorganization and rescue financing. Prior to Dalton, I worked at Al Ahlia Securities in Muscat, Oman, for more than two years as Head of Research for a $100 mn equity fund. Middle East and North African equities were key investing targets. Prior to Al Ahlia, I worked as Head of Research at ANZ Investment Bank for two years in Syndey, Australia and Mumbai, India. While setting up an Indian asset management company for Australian bank ANZ, I gained research experience in Australian mining, minerals, telecom and tourism sectors. Prior to ANZ, I worked at Unit Trust of India, Indias largest mutual fund at that time, between March 1992 and December 1996. I personally visited more than 300 companies in various parts of India and analyzed/invested in their debt/equity. I hold an MBA from Marshall School of Business, University of Southern California. I also hold an MBA from Indian Institute of Management, Ahmedabad IIM-A. I hold a B.Tech in Aerospace Engineering from Indian Institute of Technology, Kharagpur IIT-KGP. I am Chartered Financial Analyst CFA and a member of CFA Institute/CFA society of Los Angeles.
The goal as everyone knows, is to buy good stocks at a discount and sell-short overvalued stocks when they are at a premium. I have a background in business and deal with internal models, analysis, sales pitches and ad information daily. In my downtime, I am enthusiastic about the markets highs, lows and volatility. I believe in real lags between market and business reactions, with the former often in advance of the latter, and vice versa. I look to call manic enthusiasm with a distinct opportunity to go short. A change in sentiment is all it takes. I research fundamentals while scavenging for value.
Andrew Left's Citron Research (http://www.citronresearch.com/) (formally known as Stocklemon.com) seeks to expose companies whose management is in some way misleading investors. Left digs into SEC filings, financials, management histories and other data to uncover such situations, and he is usually short the stocks he writes about. Mr. Left has been publishing for 7 years and has created a track record that is unrivaled in short selling. Mr. Left has been cited in Barron's, Wall St Journal, CNBC and other major publications repeatedly for his work. Mr. Left was also an invited speaker at the reknown Master Investor Conference.
Visit: Citron Research (http://www.citronresearch.com/)
Professional investor and overall good guy. Disclaimer: By reading Mako Research reports, you agree to use the information at your own risk. In no event should Mako Research or any affiliated party be liable for any direct or indirect trading losses caused by information contained in the research reports. Research reports are not investment advice or a recommendation or solicitation to transact any securities. Mako Research is not a registered investment advisor. You agree to do your own research and due diligence before making any investment decision with respect to securities covered herein. You should assume that Mako Research stands to profit in the event the issuer’s stock declines. Research reports may contain opinions, which are based upon generally available public information, field research, inferences and deductions through due diligence and analytical processes. All information is believed to be accurate and reliable, and has been obtained from public sources. Mako Research makes no representation, express or implied, as to the accuracy, timeliness, or completeness of any such information. All expressions of opinion are subject to change without notice, and Mako Research is not obligated to update or supplement any reports or any of the information, analysis and opinion contained in them. You should assume that Mako Research has and/or will submit findings with the Securities Exchange Commission, and other entities that may find the information useful.
All opinions and research published and shared here are for the public good based on our best-efforts to help you in your own due diligence. All research presented and opinions are based on available public information. All investors are recommended to do their own work and not rely on internet message boards or blogs.
PhaseFive initiates research-intensive analysis of Healthcare and Biotechnology companies using groundbreaking scientific intelligence tools. We focus on long/short event-driven opportunities centered on clinical, regulatory and early commercial development.
Our research approach relies on synergizing diverse talents. PhaseFive’s team is built on the knowledge and vast experience of Neurobiochemistry PhDs, Big Data experts and seasoned Life Science investors. Our track record reflects our ability to assess a company’s true fair value at critical stages, looking beyond hype and misunderstood perceptions.
PhaseFive focuses on catalyst events in small-to-medium cap Healthcare companies. These catalyst events include clinical trial outcomes, regulatory procedures and commercial developments.